News SUNE BIOP OTC Markets

Equities

SBFM

US8677812054

Delayed OTC Markets Other stock markets 08:45:16 05/10/2021 pm IST			5-day change	1st Jan Change
0.1175 ^USD	-1.26%		+0.34%	+657.96%

13/05	Certain Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-MAY-2024.	CI
19/04	Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Certain Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-MAY-2024.	13/05	CI
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	22/04	AQ
Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	19/04	MT
Top Premarket Decliners	19/04	MT
Sunshine Biopharma Announces Reverse Stock Split	15/04	AQ
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement	12/04	MT
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	29/03	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Sunshine Biopharma, Inc. announced that it has received $5 million in funding	28/03	CI
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	06/03	PR
Sunshine Biopharma, Inc. announced that it expects to receive $0.01 million in funding	04/03	CI
Sunshine Biopharma, Inc. Announces Executive Changes	30/01	CI
Sunshine Biopharma Moves Principal Office to New York City	04/12	AQ
Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City	04/12	CI
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	13/11	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc	02/11	CI
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule	22/23/22	MT
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	11/23/11	AQ
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	11/23/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SUNE BIOP OTC Markets

Equities

SBFM

US8677812054

Summary

Filters